Here are six things to know:
1. BioMedical Enterprises manufactures Nitinol orthopedic implants for small bone fixation. Nitinol is a nickel-titanium alloy that provides dynamic continuous active compression.
2. The implants are indicated for treatment of bunions, hammertoes and other foot and ankle deformities as well as hand and wrist deformities.
3. The implants come ready-to-use on a sterilized, pre-loaded, disposable insertion tool.
4. The acquisition reinforces Johnson & Johnson Medical Device’s focus on strengthening DePuy Synthes’ portfolio for elective extremity procedures.
5. DePuy Synthes focuses on the foot and ankle as well as hand and wrist markets for bone fixation in trauma.
6. England Securities, LLC represented the seller, BioMedical Enterprises, in the transaction.
More articles on devices:
FDA clears First Ray’s Stealth Staple System — 5 highlights
Medtronic names Karen Parkhill EVP, CFO: 5 key notes
Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
